International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 4 (July-August 2026) Submit your research before last 3 days of August to publish your research paper in the issue of July-August.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 8 Issue 4
July-August 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Stimulants, Psychoactive Plants, and Human Optimization: Medical Gatekeeping, Prohibition, and Adult Autonomy in Drug Policy

Author(s) Dr. Elias Rubenstein
Country United States
Abstract Human societies have long used stimulant plants, psychoactive preparations, prescription medicines, commercial products, and traditional botanical substances to support wakefulness, endurance, labor, ritual, social participation, attention, motivation, fatigue resistance, performance, and human optimization. Modern drug policy regulates this field unevenly. Coffee, tea, caffeine, nicotine, energy drinks, pre-workout products, prescription stimulants, wakefulness-promoting agents, peptide-based nootropics, cognitive enhancers, and neurofunctional medicines are normalized through culture, commerce, medicine, taxation, research, or institutional use. Other forms of adult self-directed activation and optimization, especially those involving non-sanctioned psychoactive plants, fungi, compounds, or personal use outside approved medical and commercial channels, are often stigmatized, restricted, or criminalized.
This paper examines the regulatory paradox of stimulants, psychoactive plants, and human optimization. It argues that drug policy is shaped not only by pharmacological risk, but also by cultural familiarity, medical gatekeeping, market authorization, colonial history, religious-moral inheritance, social ritual, fiscal integration, workplace pressure, and state utility. Risk is not the dividing line between legality and criminality. Caffeine, nicotine, energy drinks, prescription stimulants, cognitive enhancers, alcohol, sugar consumption, extreme work, high-risk sport, and other accepted practices all carry risks under certain conditions. The central question is why some risks are normalized, commercialized, taxed, medicalized, researched, or operationalized, while others are treated as illegitimate or criminal.
The paper distinguishes pharmacological stimulants from the broader category of activation and optimization agents. It introduces self-directed activation and optimization as a regulatory concept for adult efforts to alter energy, attention, motivation, endurance, emotional state, social capacity, cognitive performance, and functional capacity. Dependence potential, cardiovascular risk, psychiatric vulnerability, dose, route, unsafe combinations, youth vulnerability, and coercive optimization pressure may justify information, labeling, quality control, truthful disclosure, civil responsibility, medical access, and targeted restrictions where concrete harm is present. Criminal prohibition requires a separate and stronger justification grounded in concrete harm, coercion, deception, youth targeting, direct third-party risk, unsafe commercialization, or the demonstrated failure of less restrictive alternatives.
The paper proposes a Liberty, Harm, and Intervention Threshold Test for evaluating stimulant substances, psychoactive plants, prescription stimulants, commercial performance products, peptide-based nootropics, cognitive enhancers, neurofunctional medicines, and non-classical activation agents. The model assesses mechanism, dose, route, preparation, supply safety, developmental risk, third-party harm, interaction burden, social coercion, cultural bias, medical double standards, jurisdictional inconsistency, market authorization, and proportionality. It concludes that coherent drug policy should move beyond moralized prohibition toward a liberty-preserving model that distinguishes concrete harm, coercive optimization pressure, unsafe markets, and adult self-risk.
Keywords stimulants, psychoactive plants, human optimization, self-directed activation, adult autonomy, drug policy, prohibition, medical gatekeeping, risk literacy, harm reduction, caffeine, coca leaf, khat, methylphenidate, modafinil, nootropics, Semax, Selank, Cerebrolysin, centrophenoxine, cognitive enhancers, energy drinks, nicotine, performance enhancement, psychoactive regulation
Field Medical / Pharmacy
Published In Volume 8, Issue 4, July-August 2026
Published On 2026-07-04
DOI https://doi.org/10.36948/ijfmr.2026.v08i04.82863
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI prefix of IJFMR is 10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 3Cover Page Vol 8 Isu 2Cover Page Vol 8 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com
Powered by Sky Research Publication and Journals